Showing 1 - 2 results of 2 for search 'for the OptimAT study group', query time: 0.02s Refine Results
  1. 1
    Apixaban and rivaroxaban's physiologically‐based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side

    Apixaban and rivaroxaban's physiologically‐based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side by Jean Terrier, Frédéric Gaspar, Pauline Gosselin, Olivier Raboud, Camille Lenoir, Victoria Rollason, Chantal Csajka, Caroline Samer, Pierre Fontana, Youssef Daali, Jean‐Luc Reny, for the OptimAT study group

    Published 2023-12-01
    Get full text
    Article
  2. 2
    Effects of different exercise modalities on cardiac dysfunction in heart failure with preserved ejection fraction

    Effects of different exercise modalities on cardiac dysfunction in heart failure with preserved ejection fraction by David Bode, Natale P.L. Rolim, Tim Guthof, Niklas Hegemann, Paulina Wakula, Uwe Primessnig, Anne Marie Ormbostad Berre, Volker Adams, Ulrik Wisløff, Burkert M. Pieske, Frank R. Heinzel, Felix Hohendanner, OptimEx Study Group

    Published 2021-06-01
    Get full text
    Article

Search Tools: